ATS 2023 Insights
ATS 2023 Insights: Effect of Ensifentrine, a Novel PDE3 and PDE4 Inhibitor, on Lung Function, Symptoms and Exacerbations in Patients With COPD: The ENHANCE Trials
By
ATS 2023 Insights
FEATURING
Antonio Anzueto
By
ATS 2023 Insights
FEATURING
Antonio Anzueto
Login to view comments.
Click here to Login
